The playing field is quite crowded when it comes to PEMF devices. There is one consistent theme that runs through all of these companies and it is that most do not have any data supporting their results. Most everyone typically points to a NASA study, which is well and good. But as far as their product, nada.
We are no different. Sure, we have an initial 24-horse study that was done years ago. And then a confluence of events impacted our next steps. Because we were successful (sales) right out of the gate, R&D was the last thought on the leaderships mind. And of course, not being equine people and new to the industry, there wasn't any idea that research would be that important to the horse crowd. This simply showed a lack of understanding with the world of a veterinarian, which is understandable since no one had an equine or veterinarian background. So you take your lumps and you learn, hopefully. And yes, we have learned.
The inventor of Cytowave is currently finalizing his newest technology, an app that will allow someone to see day-to-day results via a detailed 3D image of the injury. The app will digitize the information obtained from ultrasound scans and create an accurate 3D image that can be rotated to allow a better look at the injury and the healing taking place.
Why is this valuable? One, this leap frogs the need for data - if you can't believe the results you are seeing in a detailed image, then we can't help you. Secondly, we don't have to euthanize any horses to do this research. Although we understand this old-school approach is how a lot of data is collected, we are now at the point were we don't have to do this. Good news for horses on both fronts - no sacrificing and quicker healing.